Physician profile
Amit Dwivedi
NPI 1265541874
$405,818.62
in general payments reported to CMS, 2019-2025
47 companies · $92K in 2025
The $92K reported for 2025 was more than what 99% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General and research payments by program year, as reported to CMS.
General payments by year: 2019: $58K · 2020: $29K · 2021: $48K · 2022: $45K · 2023: $62K · 2024: $72K · 2025: $92K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $126K · Consulting Fee: $51K · Food and Beverage: $27K · Travel and Lodging: $19K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $1,500 · Honoraria: $500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $126,040.00 |
| Consulting Fee | $51,196.20 |
| Food and Beverage | $27,433.86 |
| Travel and Lodging | $18,861.97 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $1,500.00 |
| Honoraria | $500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Research payments are listed separately below. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $107,735.13 | 2019-2025 | Indigo System, Ruby Coil, Penumbra System |
| Sanara Medtech INC. | $90,804.93 | 2022-2025 | Celleraterx, Celleraterx, Biasurge |
| W. L. Gore & Associates, INC. | $68,758.27 | 2019-2025 | Gore Excluder Thoracoabdominal Branch Endoprosthesis, Gore Tag Thoracic Branch Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Boston Scientific Corporation | $33,657.57 | 2020-2025 | Enroute Transcarotid Neuroprotection System, Ekosonic, General - Therapies |
| Silk Road Medical, INC. | $32,664.51 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Abbott Laboratories | $24,035.04 | 2019-2025 | Esprit, Jeti Peripheral Catheter, Perclose Prostyle |
| Endologix LLC | $12,424.04 | 2019-2025 | Endocross Device, Torus Stent Graft System, Alto Abdominal Stent Graft System |
| Pfizer INC. | $11,630.73 | 2019-2022 | |
| Cook Incorporated | $4,800.00 | 2019 | |
| Bard Peripheral Vascular, INC. | $3,522.25 | 2019-2025 | Denali Vena Cava Filter, Pristine, Venovo |
| Cardiovascular Systems INC. | $2,854.47 | 2019-2022 | |
| Inari Medical, INC. | $2,190.79 | 2021-2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Medtronic, INC. | $1,978.14 | 2021-2025 | Ellipsys Vascular Access System, Endurant Iis, Heli-Fx Endoanchor System |
| Cook Medical LLC | $1,277.99 | 2019-2025 | Zenith Spiral-Z, Zilver Ptx, Zenith |
| Terumo Medical Corporation | $955.12 | 2019-2025 | Glidewire, Azur Cx Detachable, Angio-Seal |
Show all 45 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $894.52 | 2025 | Artix Mt, Limflow System, Hoffmann |
| Bolton Medical INC | $853.16 | 2024-2025 | Treo Abdominal Stent-Graft System, Relay Thoracic Stent-Graft With Plus Delivery System |
| Shockwave Medical, INC | $847.11 | 2019-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Baxter Healthcare | $666.18 | 2022-2024 | Floseal, Preveleak, Perclot |
| Ekos Corporation | $642.99 | 2019 | |
| Smith+Nephew, INC. | $517.80 | 2019-2024 | Pico 14, Pico 7, Renasys Touch |
| Merit Medical Systems INC | $400.00 | 2023 | Heartspan Steerble Sheath Introducer |
| Acera Surgical, INC. | $192.15 | 2020-2025 | Restrata Wound Matrix |
| Janssen Pharmaceuticals, INC | $184.01 | 2019-2022 | |
| Avinger INC. | $151.30 | 2021-2023 | Pantheris |
| Cvrx, INC. | $146.68 | 2021-2022 | |
| Integra Lifesciences Corporation | $145.54 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $120.08 | 2019-2024 | Camzyos |
| Biocompatibles, INC. | $109.71 | 2019 | |
| Philips North America LLC | $92.38 | 2019 | |
| Getinge USA Sales, LLC | $85.69 | 2022 | |
| Medtronic Vascular, INC. | $80.10 | 2019 | |
| Mimedx Group, INC. | $72.07 | 2024 | |
| Contego Medical, INC | $61.96 | 2024 | |
| Surmodics, INC. | $45.52 | 2024 | Sublime 014 Rx Pta Balloon Dilatation Catheter, Pounce Thrombectomy, Sublime Microcatheter, 018, 200cm, Straight |
| Abiomed | $41.05 | 2025 | |
| Imperative Care, INC | $38.10 | 2025 | Symphony Catheter |
| Dilon Technologies, INC. | $29.07 | 2023 | Hemoblast Bellows |
| Atricure, INC. | $25.81 | 2025 | Atricure Cryoice Cryosphere Cryoablation System |
| Ets Wound Care LLC | $21.05 | 2025 | Mirragen Advanced Wound Matrix |
| Vivus LLC | $17.39 | 2022 | |
| Acacia Pharma INC | $17.03 | 2022 | |
| Next Science LLC | $14.84 | 2019 | |
| Tei Medical INC. | $11.39 | 2019 | |
| Organogenesis INC. | $4.96 | 2019 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$500.00 in research payments reported 2019-2025. Research payments are often institution-directed and tied to clinical trials: they are reported under a clinician's name but frequently go to a hospital or research organization, and usually reflect participation in medical research.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amit Dwivedi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.